The alteration of plasma TGF-β1 levels in patients with brain tumors after tumor removal

Kaohsiung Journal of Medical Sciences

Volumn 28, Issue 6, 2012, Pages 316-321

  Loh, Joon Khim ^a,b,c   Lieu, Ann Shung ^a,b   Su, Yu Feng ^a,b   Cheng, Chi Yun ^a   Tsai, Tai Hsin ^a,b   Lin, Chih Lung ^a,b   Lee, Kung Shing ^a,b   Hwang, Shiuh Lin ^a,b   Kwan, Aij Lie ^a,b   Wang, Chih Jen ^a,b   Hong, Yi Ren ^b   Howng, Shen Long ^a,b   Chio, Chung Ching ^d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Brain tumor; Transforming growth factor beta 1; Tumor removal

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURGERY; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; GLIOSARCOMA; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; MENINGIOMA; NEURILEMOMA; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRANSFORMING GROWTH FACTOR BETA1 BLOOD LEVEL; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84861629147     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2011.11.012     Document Type: Article

References (25)

1. M.T. Jennings, and J.A. Pietenpol The role of transforming growth factor beta in glioma progression J Neurooncol 36 1998 123 140 (Pubitemid 28073669)
2. B. Kaminska, A. Wesolowska, and M. Danilkiewicz TGF beta signalling and its role in tumour pathogenesis Acta Biochim Pol 52 2005 329 337 (Pubitemid 41133768)
3. R.L. Elliott, and G.C. Blobe Role of transforming growth factor Beta in human cancer J Clin Oncol 23 2005 2078 2093 (Pubitemid 46211385)
4. H. Tsushima, S. Kawata, S. Tamura, N. Ito, Y. Shirai, and S. Kiso High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression Gastroenterology 110 1996 375 382 (Pubitemid 26043869)
5. F. Huang, E. Newman, D. Theodorescu, R.S. Kerbel, and E. Friedman Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid Cell Growth Differ 6 1995 1635 1642
6. B.C. Song, Y.H. Chung, J.A. Kim, W.B. Choi, D.D. Suh, and S.I. Pyo Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma Cancer 94 2002 175 180 (Pubitemid 34049056)
7. D. Danielpour Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1 J Immunol Methods 158 1993 17 25
8. S. Narai, M. Watanabe, H. Hasegawa, H. Nishibori, T. Endo, and T. Kubota Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer Int J Cancer 97 2002 508 511 (Pubitemid 34027811)
9. T. Schneider, M. Sailer, S. Ansorge, R. Firsching, and D. Reinhold Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma J Neurooncol 79 2006 61 65 (Pubitemid 44057419)
10. Y. Shirai, S. Kawata, S. Tamura, N. Ito, H. Tsushima, and K. Takaishi Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases Cancer 73 1994 2275 2279 (Pubitemid 24129108)
11. Z.Z. Dong, D.F. Yao, M. Yao, L.W. Qiu, L. Zong, and W. Wu Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma Hepatobiliary Pancreat Dis Int 7 2008 288 295 (Pubitemid 351895389)
12. R. Kiefer, M.L. Supler, K.V. Toyka, and W.J. Streit In situ detection of transforming growth factor-beta mRNA in experimental rat glioma and reactive glial cells Neurosci Lett 166 1994 161 164 (Pubitemid 24053818)
13. V. Samuels, J.M. Barrett, S. Bockman, C.G. Pantazis, and M.B. Allen Jr. Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas Am J Pathol 134 1989 894 902
14. N. Yamada, M. Kato, H. Yamashita, M. Nister, K. Miyazono, and C.H. Heldin Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma Int J Cancer 62 1995 386 392
15. J.D. Stiles, P.T. Ostrow, L.L. Balos, S.J. Greenberg, R. Plunkett, and W. Grand Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas J Neuropathol Exp Neurol 56 1997 435 439 (Pubitemid 27465026)
16. N. Chattopadhyay, M.M. Godbole, J TFH, and E.M. Brown Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells Brain Res Mol Brain Res 121 2004 146 150 (Pubitemid 38224180)
17. G.G. Gomez, and C.A. Kruse Mechanisms of malignant glioma immune resistance and sources of immunosuppression Gene Ther Mol Biol 10 2006 133 146 (Pubitemid 351976185)
18. J. Kobie Akporiaye Egfb. Immunosuppressive role of transforming growth factor beta in breast cancer Clin Applied Immunol Rev 3 2003 277 278
19. M. Weller, D.B. Constam, U. Malipiero, and A. Fontana Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression Eur J Immunol 24 1994 1293 1300
20. J. Boucek, T. Mrkvan, M. Chovanec, M. Kuchar, J. Betka, and V. Boucek Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck J Cell Mol Med 14 2010 426 433
21. N.M. Moutsopoulos, J. Wen, and S.M. Wahl TGF-beta and tumors-an ill-fated alliance Curr Opin Immunol 20 2008 234 240
22. B. Almand, J.I. Clark, E. Nikitina, J. van Beynen, N.R. English, and S.C. Knight Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J Immunol 166 2001 678 689 (Pubitemid 32038493)
23. C. Barbieri, M.M. Fujisawa, C.L. Yasuda, I.L. Metze, E.C. Oliveira, and L.M. Santos Effect of surgical treatment on the cellular immune response of gastric cancer patients Braz J Med Biol Res 36 2003 339 345 (Pubitemid 36442983)
24. E.A. Danna, P. Sinha, M. Gilbert, V.K. Clements, B.A. Pulaski, and S. Ostrand-Rosenberg Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease Cancer Res 64 2004 2205 2211 (Pubitemid 38339474)
25. S. Salvadori, G. Martinelli, and K. Zier Resection of solid tumors reverses T cell defects and restores protective immunity J Immunol 164 2000 2214 2220 (Pubitemid 30108782)